Cara Therapeutics Reports First Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Cara Therapeutics (CARA) Misses Q1 EPS by 7c
May 4, 2017 4:24 PM EDTCara Therapeutics (NASDAQ: CARA) reported Q1 EPS of ($0.81), $0.07 worse than the analyst estimate of ($0.74). Revenue for the quarter came in at $843 thousand versus the consensus estimate of $150 thousand.
For earnings history and earnings-related data on Cara Therapeutics (CARA) click here.
... More